Lung cancer: positive results from a therapeutic vaccine

Nantes-based biotechnology company OSE Immunotherapeutics has presented positive results from a clinical trial of its therapeutic vaccine "Tedopi" in patients with advanced lung cancer.

The results show a 41% reduction in the risk of death compared with chemotherapy, according to the company. Beyond this, cancer vaccine trials are multiplying.